Condition
Breast Cancer Invasive clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Breast Cancer Invasive clinical trials that are recruiting, at sites in 12 countries (most in United States (6), China (5), United Kingdom (2)). By phase: Phase 2 (5), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 12Countries
Newest Breast Cancer Invasive clinical trials
All recruiting trials (21)
-
ATUSA 3D automated breast ultrasound for suspicious breast lesions
This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.
-
SBRT with intratumoural pembrolizumab before neoadjuvant chemotherapy for high-risk breast cancer
This study will test whether a short course of focused radiation plus two injections of pembrolizumab into the tumor before chemotherapy helps people with high‑risk invasive breast cancer respond better to treatment.
-
Detecting cancer margins during breast surgery using advanced imaging technology
This study is testing a new imaging system that helps surgeons find cancerous tissue more accurately during breast cancer surgery to improve patient outcomes.
-
Confocal Histolog Scanner for checking margins during lumpectomy
This project will test whether using a confocal Histolog Scanner during lumpectomy helps surgeons find cancer at the edges of removed tissue and reduce the need for repeat operations in women having breast-conserving surgery.
-
Evaluating Circulating Tumor Cells in Breast Cancer Follow-up
This study is testing a new way to track cancer cells in the blood of breast cancer patients to see how their condition changes during treatment.
-
Using 68Ga-FAPi-46 PET/CT to study breast cancer
This study is testing a new imaging method using a special agent to see if it can help women with node-positive breast cancer get better information about their tumors before starting treatment.
-
Combining Serplulimab with Chemotherapy for Early-stage HR+/HER2- Breast Cancer
This study is testing if adding a new drug called serplulimab to standard chemotherapy helps people with early-stage HR+/HER2- breast cancer have better outcomes before surgery.
-
Using PET/CT to assess breast cancer treatment effectiveness
This study is testing a new imaging method to see how well neoadjuvant therapy works for patients with invasive breast cancer.
-
Comparing endoscopic-assisted and conventional breast-conserving surgery for breast cancer patients
This study is testing whether a new type of breast surgery called endoscopic-assisted surgery works better than the traditional method for women with breast cancer who have already received treatment.
-
AI-assisted radiotherapy for breast cancer after surgery
This study is testing a new AI-assisted radiotherapy method for women with invasive breast cancer after surgery to see if it can make treatment faster and more effective.
-
Using nanopore sequencing for faster breast cancer diagnosis in Tanzania
This study is testing if a new method called nanopore sequencing can help doctors in Tanzania diagnose breast cancer faster and more accurately than the usual tests.
-
Evaluating outcomes of breast-conserving surgery for cancer patients
This study is testing how well a specific type of breast surgery works for cancer patients and how it affects their quality of life and recovery, while also considering their personal choices in treatment.
-
Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients
This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.
-
Comparing continuous and intermittent use of pyrotinib for HER2-positive breast cancer
This study is testing whether taking the cancer drug pyrotinib continuously or in intervals helps people with HER2-positive breast cancer do better and feel less side effects after their initial treatment.
-
Evaluating immune and clinical responses in early-stage triple negative breast cancer with chemo-immunotherapy
This study is testing if a combination of chemotherapy and immunotherapy can help people with early-stage triple negative breast cancer by looking at their immune responses and how well the treatment works.
-
Omitting breast surgery for certain breast cancer patients after treatment
This study is testing if certain breast cancer patients who show no signs of cancer after treatment can safely skip surgery and still stay cancer-free for five years.
-
Educational media for Latinx patients undergoing radiation therapy for breast or prostate cancer
This study is testing new educational videos and materials to help Spanish-speaking Latinx patients better understand their radiation therapy for breast or prostate cancer and feel more involved in their treatment.
-
Continuing systemic therapy after local treatment for metastatic breast cancer
This study is testing if continuing treatment after local therapies can help people with metastatic breast cancer feel better and live longer.
-
Understanding how tumor shrinkage predicts cancer response in early breast cancer patients
This study tests if measuring how much breast tumors shrink during chemotherapy can help predict how well the treatment will work for women with early-stage breast cancer.
-
Preoperative low dose azacitidine for high-risk early stage breast cancer
This study is testing if a low dose of azacitidine can boost the immune response in patients with high-risk early stage breast cancer before they have surgery.
-
Using ultrasound imaging to predict breast cancer treatment response
This study tests if different types of ultrasound imaging can help predict how well breast cancer patients respond to their chemotherapy and radiotherapy treatments.
Related topics
Quick answers
How many Breast Cancer Invasive clinical trials are recruiting right now?
21, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (6 trials), China (5 trials), United Kingdom (2 trials), Canada (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.